Clinical trials for Cancer in United States

Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma

Study ID: NCT03521830

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

REmote Symptom COllection to improVE postopeRative Care

Study ID: NCT06190730

Sponsor

Medstar Health Research Institute

Olaparib and Durvalumab With Carboplatin, Etoposide, and/or Radiation Therapy for the Treatment of Extensive-Stage Small Cell Lung Cancer, PRIO Trial

Study ID: NCT04728230

Sponsor

M.D. Anderson Cancer Center

S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration

Study ID: NCT04071457

Sponsor

SWOG Cancer Research Network

In Situ Immunomodulation with CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients W/ Unresectable and Metastatic Solid Tumors

Study ID: NCT04616248

Sponsor

University of Southern California

Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer

Study ID: NCT05198830

Sponsor

National Cancer Institute (NCI)

ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCL

Study ID: NCT06693830

Sponsor

Hua-Jay J Cherng, MD

Medical Cannabis in Patients With Advanced Pancreatic Cancer

Study ID: NCT06605430

Sponsor

HealthPartners Institute

Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors

Study ID: NCT05283330

Sponsor

Orano Med LLC

The COMPASSION Study

Study ID: NCT06507930

Sponsor

Dana-Farber Cancer Institute